Development of phosphonate derivatives of gadolinium chelates for NMR imaging of calcified soft tissues
- 1 January 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (1) , 139-144
- https://doi.org/10.1021/jm00121a026
Abstract
We have synthesized several classes of gadolinium (Gd) complexes for use as NMR contrast agents in the detection of soft-tissue calcification. Class I was made up of strongly chelated GdDTPA complexes with one carboxylate arm coupled to a phosphonate-containing molecule through an amide link. Class II complexes were formed by Gd with several aminophosphonates and phosphono carboxylic acids. Class III were Gd complexes of weak chelates containing no phosphonate. The calcium-seeking ability of each complex was assessed by in vivo bone uptake. Tissue distribution in normal rats showed that only the complexes of GdDTPA modified with a diphosphonate group and GdEDTMP (EDTMP is ethylenediaminetetrakis(methylenephosponate)) showed adequate bone localization at the concentrations required for NMR contrast enhancement (.apprx. 20% of a 100 .mu.mol/kg dose).Keywords
This publication has 7 references indexed in Scilit:
- Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA.Radiology, 1986
- Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA.Radiology, 1986
- Iron-EHPG as an Hepatobiliary MR Contrast AgentJournal of Computer Assisted Tomography, 1985
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984
- New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.Radiology, 1983
- UPTAKE OF TC-99M MONOPHOSPHATE COMPLEXES IN BONE AND MYOCARDIAL NECROSIS IN ANIMALS1978
- 99mTc(Sn) phosphocreatine: Labeling characteristics and biological distributionThe International Journal of Applied Radiation and Isotopes, 1976